All Relations between dopaminergic and basal ganglia

Publication Sentence Publish Date Extraction Date Species
R Sandy. Reversal of an acute parkinsonian syndrome associated with multiple sclerosis by application of weak electromagnetic fields. The International journal of neuroscience. vol 86. issue 1-2. 1996-12-26. PMID:8828058. it is believed that in this patient parkinsonism may have existed in a subclinical form and that acute stress, which previously has been shown to precipitate symptoms of parkinson's disease, triggered the onset of parkinsonism by further reducing dopaminergic and serotonergic neurotransmission in the basal ganglia. 1996-12-26 2023-08-12 Not clear
L Spahr, R F Butterworth, S Fontaine, L Bui, G Therrien, P C Milette, L H Lebrun, J Zayed, A Leblanc, G Pomier-Layrargue. Increased blood manganese in cirrhotic patients: relationship to pallidal magnetic resonance signal hyperintensity and neurological symptoms. Hepatology (Baltimore, Md.). vol 24. issue 5. 1996-12-12. PMID:8903385. extrapyramidal symptoms could result from a toxic effect of manganese on basal ganglia dopaminergic function. 1996-12-12 2023-08-12 Not clear
K Kuwabara, S Hitoshi, N Nukina, K Ishii, T Momose, S Kubota, Y Seyama, I Kanazaw. PET analysis of a case of cerebrotendinous xanthomatosis presenting hemiparkinsonism. Journal of the neurological sciences. vol 138. issue 1-2. 1996-12-03. PMID:8791252. although mri studies could not detect any abnormality in the basal ganglia or midbrain, pet analysis using [18f]-6-fluoro-l-dopa revealed reduced uptake of dopamine into the putamen, suggesting the impairment of presynaptic dopaminergic neurons. 1996-12-03 2023-08-12 Not clear
E J Karle, K D Anderson, L Medina, A Reine. Light and electron microscopic immunohistochemical study of dopaminergic terminals in the striatal portion of the pigeon basal ganglia using antisera against tyrosine hydroxylase and dopamine. The Journal of comparative neurology. vol 369. issue 1. 1996-11-07. PMID:8723706. light and electron microscopic immunohistochemical study of dopaminergic terminals in the striatal portion of the pigeon basal ganglia using antisera against tyrosine hydroxylase and dopamine. 1996-11-07 2023-08-12 pigeon
E J Karle, K D Anderson, L Medina, A Reine. Light and electron microscopic immunohistochemical study of dopaminergic terminals in the striatal portion of the pigeon basal ganglia using antisera against tyrosine hydroxylase and dopamine. The Journal of comparative neurology. vol 369. issue 1. 1996-11-07. PMID:8723706. a dopaminergic projection from the midbrain to the striatal portion of the basal ganglia is present in reptiles, birds, and mammals. 1996-11-07 2023-08-12 pigeon
E J Karle, K D Anderson, L Medina, A Reine. Light and electron microscopic immunohistochemical study of dopaminergic terminals in the striatal portion of the pigeon basal ganglia using antisera against tyrosine hydroxylase and dopamine. The Journal of comparative neurology. vol 369. issue 1. 1996-11-07. PMID:8723706. in the present study, we used immunohistochemical labeling with antibodies against tyrosine hydroxylase (th) or dopamine (da) to study the dopaminergic input to the striatal portion of the basal ganglia in pigeons (i.e., lobus parolfactorius and paleostriatum augmentatum). 1996-11-07 2023-08-12 pigeon
V Bernard, A Gardiol, B Faucheux, B Bloch, Y Agid, E C Hirsc. Expression of glutamate receptors in the human and rat basal ganglia: effect of the dopaminergic denervation on AMPA receptor gene expression in the striatopallidal complex in Parkinson's disease and rat with 6-OHDA lesion. The Journal of comparative neurology. vol 368. issue 4. 1996-11-07. PMID:8744443. expression of glutamate receptors in the human and rat basal ganglia: effect of the dopaminergic denervation on ampa receptor gene expression in the striatopallidal complex in parkinson's disease and rat with 6-ohda lesion. 1996-11-07 2023-08-12 human
R F Butterworth, L Spahr, S Fontaine, G P Layrargue. Manganese toxicity, dopaminergic dysfunction and hepatic encephalopathy. Metabolic brain disease. vol 10. issue 4. 1996-10-24. PMID:8847990. a major cause of pallidal hyperintensity on t1-weighted mri is manganese deposition; chronic manganese intoxication in the absence of liver disease results in pallidal mr signal hyperintensity, in extrapyramidal symptoms and in selective effects on the dopaminergic neurotransmitter system in basal ganglia. 1996-10-24 2023-08-12 Not clear
F Blandini, R H Porter, J T Greenamyr. Glutamate and Parkinson's disease. Molecular neurobiology. vol 12. issue 1. 1996-10-04. PMID:8732541. degeneration of dopamine nigral neurons is followed by striatal dopaminergic denervation, which causes a cascade of functional modifications in the activity of basal ganglia nuclei. 1996-10-04 2023-08-12 Not clear
F Blandini, R H Porter, J T Greenamyr. Glutamate and Parkinson's disease. Molecular neurobiology. vol 12. issue 1. 1996-10-04. PMID:8732541. with nigrostriatal dopaminergic depletion, the glutamatergic projections from subthalamic nucleus to the basal ganglia output nuclei become overactive and there are regulatory changes in glutamate receptors in these regions. 1996-10-04 2023-08-12 Not clear
T Büttner, W Kuhn, T Müller, T Patzold, H Przunte. Color vision in Parkinson's disease: missing influence of amantadine sulphate. Clinical neuropharmacology. vol 18. issue 5. 1996-08-07. PMID:8665560. from these results, it can be concluded that the pathophysiology of dopaminergic pathways in the visual system differs from that of the basal ganglia. 1996-08-07 2023-08-12 Not clear
D J O'Boyle, J S Freeman, F W Cod. The accuracy and precision of timing of self-paced, repetitive movements in subjects with Parkinson's disease. Brain : a journal of neurology. vol 119 ( Pt 1). 1996-06-25. PMID:8624694. the theoretical import of these results is discussed in the light of several important procedural, statistical and computational issues and we conclude that tv, cv, and mdv may all vary significantly as a function of the efficacy of dopaminergic transmission in the basal ganglia. 1996-06-25 2023-08-12 human
A Berardelli, S Rona, M Inghilleri, M Manfred. Cortical inhibition in Parkinson's disease. A study with paired magnetic stimulation. Brain : a journal of neurology. vol 119 ( Pt 1). 1996-06-25. PMID:8624695. the positive effect of l-dopa suggests that dopaminergic modulation of cortical activity, most probably at basal ganglia level, is involved in the pathogenesis of this phenomenon. 1996-06-25 2023-08-12 human
B K Lipska, G E Jaskiw, A R Braun, D R Weinberge. Prefrontal cortical and hippocampal modulation of haloperidol-induced catalepsy and apomorphine-induced stereotypic behaviors in the rat. Biological psychiatry. vol 38. issue 4. 1996-02-20. PMID:8547448. effects of prefrontal cortical or hippocampal excitotoxic lesions on behavioral parameters related to dopaminergic transmission in the basal ganglia were investigated in the rat. 1996-02-20 2023-08-12 rat
J W Kebabian, P J Blanchet, P Bedar. The D-1 dopamine receptor: past, present and future an idiosyncratic review. Progress in neuro-psychopharmacology & biological psychiatry. vol 19. issue 5. 1996-02-07. PMID:8539418. the loss of the dopaminergic innervation and the subsequent repeated exposure to dopamine (derived from the exogenous dopa administered to the subjects) alters the response properties of the basal ganglia circuitry so that stimulation of dopamine receptors now elicits the dyskinetic movements. 1996-02-07 2023-08-12 human
Z Elazar, N Peleg, M Paz, G Rin. The striatal dopaminergic catalepsy mechanism is not necessary for the expression of pontine catalepsy produced by carbachol injections into the pontine reticular formation. Naunyn-Schmiedeberg's archives of pharmacology. vol 352. issue 2. 1995-12-27. PMID:7477442. these results suggest that the pontine catalepsy produced by microinjections of carbachol in prf is generated independently of the dopaminergic cataleptogenic mechanism in basal ganglia. 1995-12-27 2023-08-12 rat
J M Delfs, V M Ciaramitaro, T J Parry, M F Chessele. Subthalamic nucleus lesions: widespread effects on changes in gene expression induced by nigrostriatal dopamine depletion in rats. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 15. issue 10. 1995-12-04. PMID:7472418. this suggests that polysynaptic pathways regulated by the subthalamic nucleus contribute to the effects of dopaminergic lesions in many regions of the basal ganglia. 1995-12-04 2023-08-12 rat
J P de Mattos, A L de Ross. [Tics and Gilles de la Tourette syndrome]. Arquivos de neuro-psiquiatria. vol 53. issue 1. 1995-11-07. PMID:7575199. however, three factors have been considered: the neurochemical factor, related to the increased dopaminergic activity at the basal ganglia; the genetic factor and the non-genetic factors, for which environment more than genetic factors are involved. 1995-11-07 2023-08-12 Not clear
D L Bliwise, R L Watts, N Watts, D B Rye, D Irbe, M Hughe. Disruptive nocturnal behavior in Parkinson's disease and Alzheimer's disease. Journal of geriatric psychiatry and neurology. vol 8. issue 2. 1995-08-03. PMID:7794473. these findings raise the possibility that sundowning in pd patients may be a manifestation of dopaminergic depletion within the basal ganglia or other abnormalities involving the cholinergic, serotoninergic and/or noradrenergic systems in the brainstem. 1995-08-03 2023-08-12 Not clear
G B Frisoni, G Pizzolato, O Zanetti, A Bianchetti, F Chierichetti, M Trabucch. Corticobasal degeneration: neuropsychological assessment and dopamine D2 receptor SPECT analysis. European neurology. vol 35. issue 1. 1995-06-02. PMID:7737248. ibzm spect, which gives information about postsynaptic dopaminergic d2 receptors, showed severe reduction of tracer uptake in the right basal ganglia. 1995-06-02 2023-08-12 Not clear